ĀÜĄņĀŅĀ×

Dr. Donna Ambrosino is a renowned scientific leader for vaccine development having previously served as Chief Executive Officer at Nosocomial Vaccine Corporation and the first Chief Executive Officer of MassBiologics, University of Massachusetts Medical School. At MassBiologics, Dr. Ambrosino invented and developed multiple monoclonal antibodies in infectious disease with two now being commercial products (Zinplava and Rabishield).

Dr. Ambrosino was also a Professor of Pediatrics at University of Massachusetts Medical School, and Associate Professor of Pediatrics at the Dana-Farber Cancer Institute and Childrenā€™s Hospital, Harvard Medical School. At Harvard Medical School she was a National Institutes of Health-funded researcher.

She now serves on multiple Scientific Advisory Boards and Board of Directors as well as previously serving as Advisor to WHO, CEPI, and the Gates Foundation.